Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvalYear |
2016
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:QM01AX92
|
| gptkbp:brand |
gptkb:Galliprant
|
| gptkbp:CASNumber |
415903-37-6
|
| gptkbp:chemicalClass |
sulfonamide
piperidine |
| gptkbp:compatibleWith |
human use
|
| gptkbp:developer |
Aratana Therapeutics
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:hasMolecularFormula |
C26H29N5O3S
|
| https://www.w3.org/2000/01/rdf-schema#label |
grapiprant
|
| gptkbp:KEGGID |
D10541
|
| gptkbp:legalStatus |
veterinary prescription only
|
| gptkbp:mechanismOfAction |
EP4 prostaglandin receptor antagonist
|
| gptkbp:molecularWeight |
491.61 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL2103887
9832220 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
vomiting
diarrhea anorexia lethargy |
| gptkbp:UNII |
6Z5B6HVF6O
|
| gptkbp:usedFor |
pain management in dogs
osteoarthritis in dogs |
| gptkbp:bfsParent |
gptkb:Galliprant
|
| gptkbp:bfsLayer |
7
|